Dysphonia in Thai COVID-19 Patients
Author Information
Author(s): Suwannutsiri Thitaree, Arreenich Peerada, Sombuntham Premsuda
Primary Institution: Taksin Hospital, Medical Service Department, Bangkok Metropolitan Administration, Bangkok, Thailand
Hypothesis
What is the prevalence of dysphonia in non-hospitalized Thai COVID-19 patients and what factors are associated with it?
Conclusion
The prevalence of dysphonia among non-hospitalized COVID-19 patients in Thailand is 63.6%, linked to cough and nasal congestion, with symptoms likely to subside within 3 months.
Supporting Evidence
- 64.6% of participants reported dysphonia.
- Dysphonia was significantly associated with cough (P = 0.013) and nasal discharge (P = 0.047).
- 73.6% of patients showed improvement in voice handicap scores at the 3-month follow-up.
- Vaccination may serve as a protective factor against dysphonia.
Takeaway
Many people in Thailand who had COVID-19 but weren't in the hospital had trouble with their voice, but most of them got better after three months.
Methodology
This descriptive study collected data from healthcare workers who tested positive for COVID-19 and assessed their voice disorders using the Thai-VHI-10 questionnaire.
Potential Biases
The study may be biased due to the limited demographic diversity of participants.
Limitations
The study population was primarily female healthcare workers and relied on subjective assessments without objective evaluations.
Participant Demographics
The majority of participants were female (84.1%), aged between 22 and 60 years, with a mean age of 34.67 years.
Statistical Information
P-Value
0.013
Confidence Interval
95% CI = 53.3, 74.9
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website